Notably, despite the increased ICAM-1 expression observed in tissue sections, its overall expression levels remained the same across WT, PAK1KO, and PAK4KO cancer cell lines, suggesting that the upregulation primarily originates from the tumour stromal cells (Figure 4C) within the TME. Here, ICAM1 is linked to cancer.